+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Acne Medication Market by Therapeutic Class, Formulation, Type, Acne Type, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2020 - 2030

  • ID: 5314542
  • Report
  • October 2020
  • Region: Global
  • 525 pages
  • Next Move Strategy Consulting

FEATURED COMPANIES

  • Almirall SA.
  • Galderma S.A
  • GlaxoSmithKline Plc (GSK)
  • Johnson & Johnson
  • Mylan N.V., Pfizer Inc.
Market Definition:

At an estimated value of over USD 10.98 billion in 2019, the Global Acne Medication Market is predicted to thrive at a CAGR of 3.1% and valued at over USD 15.36 billion over the forecast year 2020-2030. Acne is the most common skin conditions typically caused by changes in structures of the skin. It affects almost millions of adolescents around the globe. Hence, there is huge demand for topical as well as oral acne medication. Topical medication includes creams, gels, and ointments that consist of retinoids, benzoyl peroxide, salicylic acid, and others. On the other hand, oral acne medication is relatively more effective where moderate to severe acne do not respond to topical agents.

Market Dynamics and Trends:

Numerous factors such as changing hormone levels, rising teenage population, and growing adoption of skincare products significantly drive the growth of global acne medication market. In addition, excessive production of oil from sebaceous glands and unhygienic lifestyle causes the occurrence of acne, thus impacting positively on the market growth. However, side-effects such as skin irritation, dry skin, and erythema or skin redness due to the utilization of acne medications is expected to hamper growth of the market. On the contrary, increased R&D in skin care along with the high market potential across untapped emerging countries is expected to be opportunistic for the market growth. Further, growing occurrence and severity of acne is one of the major factors that will fuel the market size during forecast period

Market Segmentations and Scope of the Study:

The global acne medication market share is segmented on the basis of therapeutic class, formulation, type, acne type, distribution channel, and geography. On the basis of therapeutic class, the market is categorized into retinoids, antibiotics, benzoyl peroxide, salicylic acid, and others. According to the formulation, the market is segmented into topical medications and oral medications. As per the type, the market is divided into prescription medicines and over-the-counter medicines. On the basis of acne type, the market is divided into non-inflammatory acne and inflammatory acne. As per the distribution channel, it is categorized as retail stores, e-commerce, and pharmacies & drug stores. Geographic fragmentation and analysis of each segment includes regions comprising North America, Europe, Asia Pacific and RoW.

Geographical Analysis:

In terms of geography, North America held major share of the market in 2019. This is attributed to the surge in use of skin care products and increased awareness about natural acne medication has propelled the demand for acne medication across this region. However, Asia-pacific is expected to grow rapidly with increasing market size due to the factors such as up surge in healthcare expenditure and higher demand for acne therapeutics across developing countries in the region.

Competitive Landscape:

Maximum growth opportunities make the Acne Medication market highly competitive. Some of the major players in the market are Almirall SA., Bausch Health Companies Inc., Galderma S.A, Mayne Pharma Group Limited, GlaxoSmithKline Plc (GSK), Mylan N.V., Pfizer Inc., Johnson & Johnson, Sun Pharmaceutical Industries Limited, and Teva Pharmaceutical Industries Ltd. among others. A number of developmental strategies have been adopted by companies in the past few years. For instance, in June 2020, Bausch Health Companies Inc. and Ortho Dermatologics, announced that ARAZLO (tazarotene) Lotion is available commercially to health care professionals across the U.S. ARAZLO is the tazarotene acne treatment medicine which is available in lotion formulation.

Also, in February 2020, Almirall, S.A. (ALM) announced the development of Seysara (sarecycline), the advanced tetracycline-derived oral antibiotic for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. The product is expected to be submitted to National Medical Products Administration (NMPA) in 2023.

KEY MARKET SEGMENTS:

Global Acne Medication Market- By Therapeutic Class
  • Retinoids
  • Topical & combination retinoids
  • Oral retinoid (Isotretinoin)
  • Antibiotics
  • Topical & combination antibiotics
  • Oral antibiotics
  • Benzoyl Peroxide
  • Salicylic Acid
  • Others
Global Acne Medication Market - By Formulation
  • Topical Medications
  • Oral Medications
Global Acne Medication Market - By Type
  • Prescription Medicines
  • Over-The-Counter Medicines
Global Acne Medication Market - By Acne Type
  • Non-Inflammatory Acne
  • Inflammatory Acne
Global Acne Medication Market - By Distribution Channel
  • Retail Stores
  • E-Commerce
  • Pharmacies & Drug Stores
Global Acne Medication Market - By Geography
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • RoW
  • Brazil
  • Saudi Arabia
  • South Africa
  • Remaining Countries
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Almirall SA.
  • Galderma S.A
  • GlaxoSmithKline Plc (GSK)
  • Johnson & Johnson
  • Mylan N.V., Pfizer Inc.
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1 Secondary Research
1.2.2 Data Analysis Framework
1.2.3 Market Size Estimation
1.2.4 Forecasting
1.2.5 Primary Research and Data Validation

2. Market Snapshot, 2019-2030 Million USD
2.1. Market Snapshot

3. Porter's Five Force Model Analysis

4. Market Dynamics
4.1. Growth Drivers
4.1.1 Driver 1
4.1.2 Driver 2
4.1.3 Driver 3
4.1.4 Driver 4
4.2. Challenges
4.2.1 Challenge 1
4.2.2 Challenge 2
4.3. Opportunities
4.3.1 Opportunity 1
4.3.2 Opportunity 2

5. Global Acne Medication Market, by Therapeutic Class
5.1. Overview
5.2. Retinoid
5.2.1 Global Retinoid Market, by Therapeutic Class
5.2.1.1 Topical & Combination Retinoids Market, by Region
5.2.1.1.1 North America Topical & Combination Retinoids Market, by Country
5.2.1.1.2 Europe Topical & Combination Retinoids Market, by Country
5.2.1.1.3 Asia-Pacific Topical & Combination Retinoids Market, by Country
5.2.1.1.4 Rest of World Topical & Combination Retinoids Market, by Country
5.2.1.2 Oral Retinoid (Isotretinoin) Market, by Region
5.2.1.2.1 North America Oral Retinoid (Isotretinoin) Market, by Country
5.2.1.2.2 Europe Oral Retinoid (Isotretinoin) Market, by Country
5.2.1.2.3 Asia-Pacific Oral Retinoid (Isotretinoin) Market, by Country
5.2.1.2.4 Rest of World Oral Retinoid (Isotretinoin) Market, by Country
5.2.2 Retinoid Market, by Region
5.2.2.1 North America Retinoid Market, by Country
5.2.2.2 Europe Retinoid Market, by Country
5.2.2.3 Asia-Pacific Retinoid Market, by Country
5.2.2.4 Rest of World Retinoid Market, by Country
5.3. Antibiotics
5.3.1 Global Antibiotics Market, by Therapeutic Class
5.3.1.1 Topical & Combination Antibiotics Market, by Region
5.3.1.1.1 North America Topical & Combination Antibiotics Market, by Country
5.3.1.1.2 Europe Topical & Combination Antibiotics Market, by Country
5.3.1.1.3 Asia-Pacific Topical & Combination Antibiotics Market, by Country
5.3.1.1.4 Rest of World Topical & Combination Antibiotics Market, by Country
5.3.1.2 Oral Antibiotics Market, by Region
5.3.1.2.1 North America Oral Antibiotics Market, by Country
5.3.1.2.2 Europe Oral Antibiotics Market, by Country
5.3.1.2.3 Asia-Pacific Oral Antibiotics Market, by Country
5.3.1.2.4 Rest of World Oral Antibiotics Market, by Country
5.3.2 Antibiotics Market, by Region
5.3.2.1 North America Antibiotics Market, by Country
5.3.2.2 Europe Antibiotics Market, by Country
5.3.2.3 Asia-Pacific Antibiotics Market, by Country
5.3.2.4 Rest of World Antibiotics Market, by Country
5.4. Salicylic Acid
5.4.1 Salicylic Acid Market, by Region
5.4.1.1 North America Salicylic Acid Market, by Country
5.4.1.2 Europe Salicylic Acid Market, by Country
5.4.1.3 Asia-Pacific Salicylic Acid Market, by Country
5.4.1.4 Rest of World Salicylic Acid Market, by Country
5.4.2 Benzoyl Peroxide Market, by Region
5.4.2.1 North America Benzoyl Peroxide Market, by Country
5.4.2.2 Europe Benzoyl Peroxide Market, by Country
5.4.2.3 Asia-Pacific Benzoyl Peroxide Market, by Country
5.4.2.4 Rest of World Benzoyl Peroxide Market, by Country
5.5. Other Medications
5.5.1 Other Medications Market, by Region
5.5.1.1 North America Other Medications Market, by Country
5.5.1.2 Europe Other Medications Market, by Country
5.5.1.3 Asia-Pacific Other Medications Market, by Country
5.5.1.4 Rest of World Other Medications Market, by Country

6. Global Acne Medication Market, by Formulation
6.1. Overview
6.2. Topical Medication
6.2.1 Topical Medication Market, by Region
6.2.1.1 North America Topical Medication Market, by Country
6.2.1.2 Europe Topical Medication Market, by Country
6.2.1.3 Asia-Pacific Topical Medication Market, by Country
6.2.1.4 Rest of World Topical Medication Market, by Country
6.3. Oral Medication
6.3.1 Oral Medication Market, by Region
6.3.1.1 North America Oral Medication Market, by Country
6.3.1.2 Europe Oral Medication Market, by Country
6.3.1.3 Asia-Pacific Oral Medication Market, by Country
6.3.1.4 Rest of World Oral Medication Market, by Country

7. Global Acne Medication Market, by Type
7.1. Overview
7.2. Prescription Medicines
7.2.1 Prescription Medicines Market, by Region
7.2.1.1 North America Prescription Medicines Market, by Country
7.2.1.2 Europe Prescription Medicines Market, by Country
7.2.1.3 Asia-Pacific Prescription Medicines Market, by Country
7.2.1.4 Rest of World Prescription Medicines Market, by Country
7.3. Over-The-Counter Medicines
7.3.1 Over-The-Counter Medicines Market, by Region
7.3.1.1 North America Over-The-Counter Medicines Market, by Country
7.3.1.2 Europe Over-The-Counter Medicines Market, by Country
7.3.1.3 Asia-Pacific Over-The-Counter Medicines Market, by Country
7.3.1.4 Rest of World Over-The-Counter Medicines Market, by Country

8. Global Acne Medication Market, by Acne Type
8.1. Overview
8.2. Non-Inflammatory Acne
8.2.1 Non-Inflammatory Acne Market, by Region
8.2.1.1 North America Non-Inflammatory Acne Market, by Country
8.2.1.2 Europe Non-Inflammatory Acne Market, by Country
8.2.1.3 Asia-Pacific Non-Inflammatory Acne Market, by Country
8.2.1.4 Rest of World Non-Inflammatory Acne Market, by Country
8.3. Inflammatory Acne
8.3.1 Inflammatory Acne Market, by Region
8.3.1.1 North America Inflammatory Acne Market, by Country
8.3.1.2 Europe Inflammatory Acne Market, by Country
8.3.1.3 Asia-Pacific Inflammatory Acne Market, by Country
8.3.1.4 Rest of World Inflammatory Acne Market, by Country

9. Global Acne Medication Market, by Distribution Channel
9.1. Overview
9.2. Retail Store
9.2.1 Retail Store Market, by Region
9.2.1.1 North America Retail Store Market, by Country
9.2.1.2 Europe Retail Store Market, by Country
9.2.1.3 Asia-Pacific Retail Store Market, by Country
9.2.1.4 Rest of World Retail Store Market, by Country
9.3. Pharmacy & Drug Store
9.3.1 Pharmacy & Drug Store Market, by Region
9.3.1.1 North America Pharmacy & Drug Store Market, by Country
9.3.1.2 Europe Pharmacy & Drug Store Market, by Country
9.3.1.3 Asia-Pacific Pharmacy & Drug Store Market, by Country
9.3.1.4 Rest of World Pharmacy & Drug Store Market, by Country
9.4. E-Commerce
9.4.1 E-Commerce Market, by Region
9.4.1.1 North America E-Commerce Market, by Country
9.4.1.2 Europe E-Commerce Market, by Country
9.4.1.3 Asia-Pacific E-Commerce Market, by Country
9.4.1.4 Rest of World E-Commerce Market, by Country

10. Global Acne Medication Market, by Region
10.1. Overview
10.2. North America
10.2.1 North America Acne Medication Market, by Therapeutic Class
10.2.1.1 North America Retinoid Market, by Therapeutic Class
10.2.1.2 North America Antibiotics Market, by Therapeutic Class
10.2.2 North America Acne Medication Market, by Formulation
10.2.3 North America Acne Medication Market, by Type
10.2.4 North America Acne Medication Market, by Acne Type
10.2.5 North America Acne Medication Market, by Distribution Channel
10.2.6 North America Acne Medication, Market by Country
10.2.6.1 U.S.
10.2.6.1.1 U.S. Acne Medication Market, by Therapeutic Class
10.2.6.1.1.1. U.S. Retinoid Market, by Therapeutic Class
10.2.6.1.1.2. U.S. Antibiotics Market, by Therapeutic Class
10.2.6.1.2 U.S. Acne Medication Market, by Formulation
10.2.6.1.3 U.S. Acne Medication Market, by Type
10.2.6.1.4 U.S. Acne Medication Market, by Acne Type
10.2.6.1.5 U.S. Acne Medication Market, by Distribution Channel
10.2.6.2 Canada
10.2.6.2.1 Canada Acne Medication Market, by Therapeutic Class
10.2.6.2.1.1. Canada Retinoid Market, by Therapeutic Class
10.2.6.2.1.2. Canada Antibiotics Market, by Therapeutic Class
10.2.6.2.2 Canada Acne Medication Market, by Formulation
10.2.6.2.3 Canada Acne Medication Market, by Type
10.2.6.2.4 Canada Acne Medication Market, by Acne Type
10.2.6.2.5 Canada Acne Medication Market, by Distribution Channel
10.2.6.3 Mexico
10.2.6.3.1 Mexico Acne Medication Market, by Therapeutic Class
10.2.6.3.1.1. Mexico Retinoid Market, by Therapeutic Class
10.2.6.3.1.2. Mexico Antibiotics Market, by Therapeutic Class
10.2.6.3.2 Mexico Acne Medication Market, by Formulation
10.2.6.3.3 Mexico Acne Medication Market, by Type
10.2.6.3.4 Mexico Acne Medication Market, by Acne Type
10.2.6.3.5 Mexico Acne Medication Market, by Distribution Channel
10.3. Europe
10.3.1 Europe Acne Medication Market, by Therapeutic Class
10.3.1.1 Europe Retinoid Market, by Therapeutic Class
10.3.1.2 Europe Antibiotics Market, by Therapeutic Class
10.3.2 Europe Acne Medication Market, by Formulation
10.3.3 Europe Acne Medication Market, by Type
10.3.4 Europe Acne Medication Market, by Acne Type
10.3.5 Europe Acne Medication Market, by Distribution Channel
10.3.6 Europe Acne Medication, Market by Country
10.3.6.1 UK
10.3.6.1.1 UK Acne Medication Market, by Therapeutic Class
10.3.6.1.1.1. UK Retinoid Market, by Therapeutic Class
10.3.6.1.1.2. UK Antibiotics Market, by Therapeutic Class
10.3.6.1.2 UK Acne Medication Market, by Formulation
10.3.6.1.3 UK Acne Medication Market, by Type
10.3.6.1.4 UK Acne Medication Market, by Acne Type
10.3.6.1.5 UK Acne Medication Market, by Distribution Channel
10.3.6.2 Germany
10.3.6.2.1 Germany Acne Medication Market, by Therapeutic Class
10.3.6.2.1.1. Germany Retinoid Market, by Therapeutic Class
10.3.6.2.1.2. Germany Antibiotics Market, by Therapeutic Class
10.3.6.2.2 Germany Acne Medication Market, by Formulation
10.3.6.2.3 Germany Acne Medication Market, by Type
10.3.6.2.4 Germany Acne Medication Market, by Acne Type
10.3.6.2.5 Germany Acne Medication Market, by Distribution Channel
10.3.6.3 France
10.3.6.3.1 France Acne Medication Market, by Therapeutic Class
10.3.6.3.1.1. France Retinoid Market, by Therapeutic Class
10.3.6.3.1.2. France Antibiotics Market, by Therapeutic Class
10.3.6.3.2 France Acne Medication Market, by Formulation
10.3.6.3.3 France Acne Medication Market, by Type
10.3.6.3.4 France Acne Medication Market, by Acne Type
10.3.6.3.5 France Acne Medication Market, by Distribution Channel
10.3.6.4 Italy
10.3.6.4.1 Italy Acne Medication Market, by Therapeutic Class
10.3.6.4.1.1. Italy Retinoid Market, by Therapeutic Class
10.3.6.4.1.2. Italy Antibiotics Market, by Therapeutic Class
10.3.6.4.2 Italy Acne Medication Market, by Formulation
10.3.6.4.3 Italy Acne Medication Market, by Type
10.3.6.4.4 Italy Acne Medication Market, by Acne Type
10.3.6.4.5 Italy Acne Medication Market, by Distribution Channel
10.3.6.5 Spain
10.3.6.5.1 Spain Acne Medication Market, by Therapeutic Class
10.3.6.5.1.1. Spain Retinoid Market, by Therapeutic Class
10.3.6.5.1.2. Spain Antibiotics Market, by Therapeutic Class
10.3.6.5.2 Spain Acne Medication Market, by Formulation
10.3.6.5.3 Spain Acne Medication Market, by Type
10.3.6.5.4 Spain Acne Medication Market, by Acne Type
10.3.6.5.5 Spain Acne Medication Market, by Distribution Channel
10.3.6.6 Rest of Europe
10.3.6.6.1 Rest of Europe Acne Medication Market, by Therapeutic Class
10.3.6.6.1.1. Rest of Europe Retinoid Market, by Therapeutic Class
10.3.6.6.1.2. Rest of Europe Antibiotics Market, by Therapeutic Class
10.3.6.6.2 Rest of Europe Acne Medication Market, by Formulation
10.3.6.6.3 Rest of Europe Acne Medication Market, by Type
10.3.6.6.4 Rest of Europe Acne Medication Market, by Acne Type
10.3.6.6.5 Rest of Europe Acne Medication Market, by Distribution Channel
10.4. Asia-Pacific
10.4.1 Asia-Pacific Acne Medication Market, by Therapeutic Class
10.4.1.1 Asia-Pacific Retinoid Market, by Therapeutic Class
10.4.1.2 Asia-Pacific Antibiotics Market, by Therapeutic Class
10.4.2 Asia-Pacific Acne Medication Market, by Formulation
10.4.3 Asia-Pacific Acne Medication Market, by Type
10.4.4 Asia-Pacific Acne Medication Market, by Acne Type
10.4.5 Asia-Pacific Acne Medication Market, by Distribution Channel
10.4.6 Asia-Pacific Acne Medication, Market by Country
10.4.6.1 India
10.4.6.1.1 India Acne Medication Market, by Therapeutic Class
10.4.6.1.1.1. India Retinoid Market, by Therapeutic Class
10.4.6.1.1.2. India Antibiotics Market, by Therapeutic Class
10.4.6.1.2 India Acne Medication Market, by Formulation
10.4.6.1.3 India Acne Medication Market, by Type
10.4.6.1.4 India Acne Medication Market, by Acne Type
10.4.6.1.5 India Acne Medication Market, by Distribution Channel
10.4.6.2 China
10.4.6.2.1 China Acne Medication Market, by Therapeutic Class
10.4.6.2.1.1. China Retinoid Market, by Therapeutic Class
10.4.6.2.1.2. China Antibiotics Market, by Therapeutic Class
10.4.6.2.2 China Acne Medication Market, by Formulation
10.4.6.2.3 China Acne Medication Market, by Type
10.4.6.2.4 China Acne Medication Market, by Acne Type
10.4.6.2.5 China Acne Medication Market, by Distribution Channel
10.4.6.3 Japan
10.4.6.3.1 Japan Acne Medication Market, by Therapeutic Class
10.4.6.3.1.1. Japan Retinoid Market, by Therapeutic Class
10.4.6.3.1.2. Japan Antibiotics Market, by Therapeutic Class
10.4.6.3.2 Japan Acne Medication Market, by Formulation
10.4.6.3.3 Japan Acne Medication Market, by Type
10.4.6.3.4 Japan Acne Medication Market, by Acne Type
10.4.6.3.5 Japan Acne Medication Market, by Distribution Channel
10.4.6.4 South Korea
10.4.6.4.1 South Korea Acne Medication Market, by Therapeutic Class
10.4.6.4.1.1. South Korea Retinoid Market, by Therapeutic Class
10.4.6.4.1.2. South Korea Antibiotics Market, by Therapeutic Class
10.4.6.4.2 South Korea Acne Medication Market, by Formulation
10.4.6.4.3 South Korea Acne Medication Market, by Type
10.4.6.4.4 South Korea Acne Medication Market, by Acne Type
10.4.6.4.5 South Korea Acne Medication Market, by Distribution Channel
10.4.6.5 Australia
10.4.6.5.1 Australia Acne Medication Market, by Therapeutic Class
10.4.6.5.1.1. Australia Retinoid Market, by Therapeutic Class
10.4.6.5.1.2. Australia Antibiotics Market, by Therapeutic Class
10.4.6.5.2 Australia Acne Medication Market, by Formulation
10.4.6.5.3 Australia Acne Medication Market, by Type
10.4.6.5.4 Australia Acne Medication Market, by Acne Type
10.4.6.5.5 Australia Acne Medication Market, by Distribution Channel
10.4.6.6 Rest of Asia-Pacific
10.4.6.6.1 Rest of Asia-Pacific Acne Medication Market, by Therapeutic Class
10.4.6.6.1.1. Rest of Asia-Pacific Retinoid Market, by Therapeutic Class
10.4.6.6.1.2. Rest of Asia-Pacific Antibiotics Market, by Therapeutic Class
10.4.6.6.2 Rest of Asia-Pacific Acne Medication Market, by Formulation
10.4.6.6.3 Rest of Asia-Pacific Acne Medication Market, by Type
10.4.6.6.4 Rest of Asia-Pacific Acne Medication Market, by Acne Type
10.4.6.6.5 Rest of Asia-Pacific Acne Medication Market, by Distribution Channel
10.5. Rest of World
10.5.1 Rest of World Acne Medication Market, by Therapeutic Class
10.5.1.1 Rest of World Retinoid Market, by Therapeutic Class
10.5.1.2 Rest of World Antibiotics Market, by Therapeutic Class
10.5.2 Rest of World Acne Medication Market, by Formulation
10.5.3 Rest of World Acne Medication Market, by Type
10.5.4 Rest of World Acne Medication Market, by Acne Type
10.5.5 Rest of World Acne Medication Market, by Distribution Channel
10.5.6 Rest of World Acne Medication, Market by Country
10.5.6.1 Brazil
10.5.6.1.1 Brazil Acne Medication Market, by Therapeutic Class
10.5.6.1.1.1. Brazil Retinoid Market, by Therapeutic Class
10.5.6.1.1.2. Brazil Antibiotics Market, by Therapeutic Class
10.5.6.1.2 Brazil Acne Medication Market, by Formulation
10.5.6.1.3 Brazil Acne Medication Market, by Type
10.5.6.1.4 Brazil Acne Medication Market, by Acne Type
10.5.6.1.5 Brazil Acne Medication Market, by Distribution Channel
10.5.6.2 Saudi Arabia
10.5.6.2.1 Saudi Arabia Acne Medication Market, by Therapeutic Class
10.5.6.2.1.1. Saudi Arabia Retinoid Market, by Therapeutic Class
10.5.6.2.1.2. Saudi Arabia Antibiotics Market, by Therapeutic Class
10.5.6.2.2 Saudi Arabia Acne Medication Market, by Formulation
10.5.6.2.3 Saudi Arabia Acne Medication Market, by Type
10.5.6.2.4 Saudi Arabia Acne Medication Market, by Acne Type
10.5.6.2.5 Saudi Arabia Acne Medication Market, by Distribution Channel
10.5.6.3 South Africa
10.5.6.3.1 South Africa Acne Medication Market, by Therapeutic Class
10.5.6.3.1.1. South Africa Retinoid Market, by Therapeutic Class
10.5.6.3.1.2. South Africa Antibiotics Market, by Therapeutic Class
10.5.6.3.2 South Africa Acne Medication Market, by Formulation
10.5.6.3.3 South Africa Acne Medication Market, by Type
10.5.6.3.4 South Africa Acne Medication Market, by Acne Type
10.5.6.3.5 South Africa Acne Medication Market, by Distribution Channel
10.5.6.4 Remaining Countries
10.5.6.4.1 Remaining Countries Acne Medication Market, by Therapeutic Class
10.5.6.4.1.1. Remaining Countries Retinoid Market, by Therapeutic Class
10.5.6.4.1.2. Remaining Countries Antibiotics Market, by Therapeutic Class
10.5.6.4.2 Remaining Countries Acne Medication Market, by Formulation
10.5.6.4.3 Remaining Countries Acne Medication Market, by Type
10.5.6.4.4 Remaining Countries Acne Medication Market, by Acne Type
10.5.6.4.5 Remaining Countries Acne Medication Market, by Distribution Channel

11. Company Profiles
11.1. Almirall Sa
11.1.1 Company Overview
11.1.2 Company Snapshot
11.1.3 Operating Business Segments
11.1.4 Product Portfolio
11.1.5 Business Performance
11.1.6 Key Strategic Moves and Development
11.2. Bausch Health Companies Inc.
11.2.1 Company Overview
11.2.2 Company Snapshot
11.2.3 Operating Business Segments
11.2.4 Product Portfolio
11.2.5 Business Performance
11.2.6 Key Strategic Moves and Development
11.3. GlaxoSmithKline plc (Gsk)
11.3.1 Company Overview
11.3.2 Company Snapshot
11.3.3 Operating Business Segments
11.3.4 Product Portfolio
11.3.5 Business Performance
11.3.6 Key Strategic Moves and Development
11.4. Johnson & Johnson
11.4.1 Company Overview
11.4.2 Company Snapshot
11.4.3 Operating Business Segments
11.4.4 Product Portfolio
11.4.5 Business Performance
11.4.6 Key Strategic Moves and Development
11.5. Galderma S.A.
11.5.1 Company Overview
11.5.2 Company Snapshot
11.5.3 Operating Business Segments
11.5.4 Product Portfolio
11.5.5 Business Performance
11.5.6 Key Strategic Moves and Development
11.6. Mayne Pharma Group Limited
11.6.1 Company Overview
11.6.2 Company Snapshot
11.6.3 Operating Business Segments
11.6.4 Product Portfolio
11.6.5 Business Performance
11.6.6 Key Strategic Moves and Development
11.7. Mylan N.V.
11.7.1 Company Overview
11.7.2 Company Snapshot
11.7.3 Operating Business Segments
11.7.4 Product Portfolio
11.7.5 Business Performance
11.7.6 Key Strategic Moves and Development
11.8. Sun Pharmaceutical Industries Limited
11.8.1 Company Overview
11.8.2 Company Snapshot
11.8.3 Operating Business Segments
11.8.4 Product Portfolio
11.8.5 Business Performance
11.8.6 Key Strategic Moves and Development
11.9. Pfizer Inc.
11.9.1 Company Overview
11.9.2 Company Snapshot
11.9.3 Operating Business Segments
11.9.4 Product Portfolio
11.9.5 Business Performance
11.9.6 Key Strategic Moves and Development
11.10. Teva Pharmaceutical Industries Ltd.
11.10.1 Company Overview
11.10.2 Company Snapshot
11.10.3 Operating Business Segments
11.10.4 Product Portfolio
11.10.5 Business Performance
11.10.6 Key Strategic Moves and Development
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Almirall SA.
  • Galderma S.A
  • GlaxoSmithKline Plc (GSK)
  • Johnson & Johnson
  • Mylan N.V., Pfizer Inc.
Acne Medication: Global Market Size, Trends, Competitive, Historical & Forecast Analysis, 2020 - 2030. Changing hormone levels, rising teenage population, and growing adoption of skincare products significantly drive the growth of global acne medication market.

Acne is the most common skin conditions typically caused by changes in structures of the skin. It affects almost millions of adolescents around the globe. Hence, there is huge demand for topical as well as oral acne medication. Excessive production of oil from sebaceous glands and unhygienic lifestyle causes the occurrence of acne, thus impacting positively on the market growth. However, side-effects such as skin irritation, dry skin, and erythema or skin redness due to the utilization of acne medications is expected to hamper growth of the market.

The global acne medication market share is segmented on the basis of therapeutic class, formulation, type, acne type, distribution channel, and geography. On the basis of therapeutic class, the market is categorized into retinoids, antibiotics, benzoyl peroxide, salicylic acid, and others. According to the formulation, the market is segmented into topical medications and oral medications. As per the type, the market is divided into prescription medicines and over-the-counter medicines. On the basis of acne type, the market is divided into non-inflammatory acne and inflammatory acne. As per the distribution channel, it is categorized as retail stores, e-commerce, and pharmacies & drug stores. Geographic fragmentation and analysis of each segment includes regions comprising North America, Europe, Asia Pacific and RoW.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Almirall SA.
  • Bausch Health Companies Inc.
  • Galderma S.A
  • Mayne Pharma Group Limited
  • GlaxoSmithKline Plc (GSK)
  • Mylan N.V., Pfizer Inc.
  • Johnson & Johnson
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll